Compare CATY & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CATY | MMED |
|---|---|---|
| Founded | 1962 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | 1996 | 2026 |
| Metric | CATY | MMED |
|---|---|---|
| Price | $58.99 | $14.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $52.50 | $22.56 |
| AVG Volume (30 Days) | 381.5K | ★ 841.5K |
| Earning Date | 04-22-2026 | 06-03-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | ★ 14.94 | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $53,793,000.00 | N/A |
| Revenue This Year | $20.37 | $15.99 |
| Revenue Next Year | $5.41 | $10.00 |
| P/E Ratio | $45.61 | ★ N/A |
| Revenue Growth | ★ 2.93 | N/A |
| 52 Week Low | $43.69 | $10.65 |
| 52 Week High | $61.55 | $17.86 |
| Indicator | CATY | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 59.68 |
| Support Level | $55.67 | $12.80 |
| Resistance Level | N/A | $15.74 |
| Average True Range (ATR) | 1.24 | 0.97 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 55.60 | 78.28 |
Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credit, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities, and advisory services.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.